| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.29e-09 | 37 | 112 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.58e-09 | 38 | 112 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.74e-05 | 11 | 112 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ADAMTS19 ERVK-7 ERVK-21 ERVK-9 F3 ADAMTS16 ERVK-8 ERVK-19 ERVK-24 ESPL1 | 3.03e-05 | 430 | 112 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 RAPSN COPA RPS12 ERVK-7 ERVK-21 ERVK-9 CLDN11 VWA5A ASPH ERVK-8 ERVK-19 ERVK-24 RPL3L COL1A2 RPL19 | 3.70e-05 | 891 | 112 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 5.98e-05 | 14 | 112 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | KDEL sequence binding | 9.32e-05 | 3 | 112 | 2 | GO:0005046 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.12e-04 | 21 | 112 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | ER retention sequence binding | 3.08e-04 | 5 | 112 | 2 | GO:0046923 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 ADAMTS19 ERVK-7 ERVK-21 ERVK-9 F3 ADAMTS16 ERVK-8 ERVK-19 ERVK-24 ESPL1 | 1.12e-03 | 654 | 112 | 11 | GO:0008233 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.16e-03 | 37 | 112 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.26e-03 | 38 | 112 | 3 | GO:0034061 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 7.28e-06 | 85 | 113 | 6 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 7.28e-06 | 85 | 113 | 6 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 9.50e-06 | 89 | 113 | 6 | GO:0006949 | |
| GeneOntologyBiologicalProcess | DNA integration | 4.40e-05 | 13 | 113 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | regulation of positive thymic T cell selection | 8.89e-05 | 3 | 113 | 2 | GO:1902232 | |
| Domain | - | COPA IFT172 LRRK2 CDC20B NOL10 DCAF12L2 HIRA NBAS WDHD1 VPS41 SMU1 | 4.35e-06 | 333 | 110 | 11 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | COPA IFT172 LRRK2 CDC20B NOL10 DCAF12L2 HIRA NBAS WDHD1 VPS41 SMU1 | 4.60e-06 | 335 | 110 | 11 | IPR015943 |
| Domain | WD40_repeat_dom | COPA IFT172 LRRK2 CDC20B NOL10 DCAF12L2 HIRA WDHD1 VPS41 SMU1 | 1.03e-05 | 297 | 110 | 10 | IPR017986 |
| Domain | WD40 | 2.96e-05 | 268 | 110 | 9 | SM00320 | |
| Domain | WD40_repeat | 3.32e-05 | 272 | 110 | 9 | IPR001680 | |
| Domain | TSP_1 | 3.46e-05 | 63 | 110 | 5 | PF00090 | |
| Domain | WD_REPEATS_1 | 3.94e-05 | 278 | 110 | 9 | PS00678 | |
| Domain | TSP1 | 4.03e-05 | 65 | 110 | 5 | SM00209 | |
| Domain | TSP1_rpt | 4.03e-05 | 65 | 110 | 5 | IPR000884 | |
| Domain | TSP1 | 4.03e-05 | 65 | 110 | 5 | PS50092 | |
| Domain | WD_REPEATS_2 | 4.05e-05 | 279 | 110 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 4.05e-05 | 279 | 110 | 9 | PS50294 | |
| Domain | PLAC | 6.90e-05 | 14 | 110 | 3 | PF08686 | |
| Domain | ER_ret_rcpt | 1.03e-04 | 3 | 110 | 2 | IPR000133 | |
| Domain | GPCR_2_brain_angio_inhib | 1.03e-04 | 3 | 110 | 2 | IPR008077 | |
| Domain | ER_lumen_recept | 1.03e-04 | 3 | 110 | 2 | PF00810 | |
| Domain | ER_LUMEN_RECEPTOR_1 | 1.03e-04 | 3 | 110 | 2 | PS00951 | |
| Domain | ER_LUMEN_RECEPTOR_2 | 1.03e-04 | 3 | 110 | 2 | PS00952 | |
| Domain | PLAC | 1.80e-04 | 19 | 110 | 3 | PS50900 | |
| Domain | PLAC | 1.80e-04 | 19 | 110 | 3 | IPR010909 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.68e-04 | 24 | 110 | 3 | IPR013273 | |
| Domain | WD40 | 8.60e-04 | 259 | 110 | 7 | PF00400 | |
| Domain | Ptc/Disp | 1.20e-03 | 9 | 110 | 2 | IPR003392 | |
| Domain | Patched | 1.20e-03 | 9 | 110 | 2 | PF02460 | |
| Domain | SET | 1.80e-03 | 41 | 110 | 3 | PF00856 | |
| Domain | GAIN_dom_N | 1.83e-03 | 11 | 110 | 2 | IPR032471 | |
| Domain | GAIN | 1.83e-03 | 11 | 110 | 2 | PF16489 | |
| Domain | SET | 2.51e-03 | 46 | 110 | 3 | SM00317 | |
| Domain | SSD | 2.57e-03 | 13 | 110 | 2 | IPR000731 | |
| Domain | SSD | 2.57e-03 | 13 | 110 | 2 | PS50156 | |
| Domain | WD40_repeat_CS | 2.86e-03 | 164 | 110 | 5 | IPR019775 | |
| Domain | SET_dom | 3.19e-03 | 50 | 110 | 3 | IPR001214 | |
| Domain | SET | 3.19e-03 | 50 | 110 | 3 | PS50280 | |
| Domain | NAP_family | 4.41e-03 | 17 | 110 | 2 | IPR002164 | |
| Domain | NAP | 4.41e-03 | 17 | 110 | 2 | PF00956 | |
| Pubmed | 3.49e-10 | 12 | 120 | 5 | 14557543 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 6.72e-10 | 5 | 120 | 4 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 3.90e-08 | 94 | 120 | 7 | 21542922 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.60e-07 | 4 | 120 | 3 | 10469592 | |
| Pubmed | 7.95e-07 | 6 | 120 | 3 | 15063128 | ||
| Pubmed | 4.72e-06 | 10 | 120 | 3 | 12970426 | ||
| Pubmed | 6.40e-06 | 75 | 120 | 5 | 20637190 | ||
| Pubmed | 7.19e-06 | 286 | 120 | 8 | 32041737 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 8212584 | ||
| Pubmed | Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. | 1.18e-05 | 2 | 120 | 2 | 21874051 | |
| Pubmed | How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. | 1.18e-05 | 2 | 120 | 2 | 7889411 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 26942878 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 8402693 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 1639500 | ||
| Pubmed | Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases. | 1.18e-05 | 2 | 120 | 2 | 24253447 | |
| Pubmed | The natural history and immunopathology of outbred athymic (nude) mice. | 1.18e-05 | 2 | 120 | 2 | 1104226 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 8097186 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 17592270 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 22096586 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.18e-05 | 2 | 120 | 2 | 9460924 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 8119666 | ||
| Pubmed | Identification of a cellular ligand for the natural cytotoxicity receptor NKp44. | 1.18e-05 | 2 | 120 | 2 | 23958951 | |
| Pubmed | Foxn1 and Prkdc genes are important for testis function: evidence from nude and scid adult mice. | 1.18e-05 | 2 | 120 | 2 | 31950264 | |
| Pubmed | Deficiency of the cytoskeletal protein SPECC1L leads to oblique facial clefting. | 1.18e-05 | 2 | 120 | 2 | 21703590 | |
| Pubmed | Lack of B cell leakiness in BALB/cA-nu, scid double mutant mice. | 1.18e-05 | 2 | 120 | 2 | 11326425 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 16169466 | ||
| Pubmed | SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth. | 1.18e-05 | 2 | 120 | 2 | 28073696 | |
| Pubmed | Site and strain-specific variation in gut microbiota profiles and metabolism in experimental mice. | 1.18e-05 | 2 | 120 | 2 | 20052418 | |
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | 1.93e-05 | 328 | 120 | 8 | 23398456 | |
| Pubmed | 3.15e-05 | 18 | 120 | 3 | 18664271 | ||
| Pubmed | Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells. | 3.53e-05 | 3 | 120 | 2 | 15514013 | |
| Pubmed | Cell-type-specific differences in KDEL receptor clustering in mammalian cells. | 3.53e-05 | 3 | 120 | 2 | 32645101 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 9971820 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 7717446 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 9533023 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 15225653 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 23687340 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 17010584 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 35767962 | ||
| Pubmed | Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. | 3.53e-05 | 3 | 120 | 2 | 7989611 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 33311516 | ||
| Pubmed | A molecular specificity code for the three mammalian KDEL receptors. | 3.53e-05 | 3 | 120 | 2 | 18086916 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 10516026 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 17967861 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 33707149 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 16808805 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 9118249 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 37652013 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 15699117 | ||
| Pubmed | Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells. | 3.53e-05 | 3 | 120 | 2 | 32768387 | |
| Pubmed | Defective killing of Candida albicans hyphae by neutrophils from beige mice. | 3.53e-05 | 3 | 120 | 2 | 7769315 | |
| Pubmed | COPA TRAPPC5 DMAC2 RPS12 CAPZB NAP1L1 SPECC1L SKP2 SPECC1 ENY2 HIRA ACSL3 NBAS ASPH SMU1 PRKDC | 3.69e-05 | 1440 | 120 | 16 | 30833792 | |
| Pubmed | B1 B lymphocytes play a critical role in host protection against lymphatic filarial parasites. | 7.05e-05 | 4 | 120 | 2 | 10684864 | |
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 10202929 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 33762355 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 19487675 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 16286021 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 30174304 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 29628393 | ||
| Pubmed | ADAMTS-3, -13, -16, and -19 levels in patients with habitual abortion. | 7.05e-05 | 4 | 120 | 2 | 28088271 | |
| Pubmed | Effect of immunodeficiency on diabetogenesis in genetically diabetic (db/db) mice. | 7.05e-05 | 4 | 120 | 2 | 3553324 | |
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 18469815 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 23960238 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 31451788 | ||
| Pubmed | Strain-dependent leakiness of mice with severe combined immune deficiency. | 7.05e-05 | 4 | 120 | 2 | 8473734 | |
| Pubmed | Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells. | 7.05e-05 | 4 | 120 | 2 | 19349693 | |
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 15578092 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 7983737 | ||
| Pubmed | Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. | 7.05e-05 | 4 | 120 | 2 | 22343031 | |
| Pubmed | 7.29e-05 | 396 | 120 | 8 | 26687479 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | LRRC66 RPS12 NAP1L1 FBXL12 NAP1L3 ENY2 SRRT RBM22 CPSF4 GLG1 SMU1 RPL19 | 8.61e-05 | 922 | 120 | 12 | 27609421 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | COPA RPS12 CAPZB NAP1L1 NOL10 SPECC1L SPECC1 SRRT PTPN2 RBM22 ASPH SMU1 PRKDC RPL19 | 1.14e-04 | 1257 | 120 | 14 | 36526897 |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.17e-04 | 5 | 120 | 2 | 11401426 | |
| Pubmed | 1.17e-04 | 5 | 120 | 2 | 10871850 | ||
| Pubmed | DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population. | 1.17e-04 | 5 | 120 | 2 | 21682944 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ADGRB2 FBXL12 SFI1 ITGB5 HIRA SIRT2 DNAJC14 CHST15 NF2 PRKDC ESPL1 ANKRD16 MYBL2 | 1.19e-04 | 1105 | 120 | 13 | 35748872 |
| Pubmed | 1.23e-04 | 547 | 120 | 9 | 37267103 | ||
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 1.30e-04 | 321 | 120 | 7 | 32098917 | |
| Pubmed | COPA IFT172 NAP1L1 NAP1L3 SPECC1 SETDB1 RBM22 GDAP1L1 DNAJC14 NF2 MTIF2 ZNF197 DGCR8 PRKDC | 1.44e-04 | 1285 | 120 | 14 | 35914814 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | COPA RPS12 NOL10 ENY2 HIRA ACSL3 SRRT RBM22 CPSF4 ASPH SMU1 PRKDC MYBL2 RPL19 | 1.54e-04 | 1294 | 120 | 14 | 30804502 |
| Pubmed | 1.75e-04 | 6 | 120 | 2 | 21841822 | ||
| Pubmed | 1.75e-04 | 6 | 120 | 2 | 17438029 | ||
| Pubmed | Role of gut cryptopatches in early extrathymic maturation of intestinal intraepithelial T cells. | 1.75e-04 | 6 | 120 | 2 | 10725718 | |
| Pubmed | CD81 Controls Beige Fat Progenitor Cell Growth and Energy Balance via FAK Signaling. | 1.75e-04 | 6 | 120 | 2 | 32615086 | |
| Pubmed | 1.75e-04 | 6 | 120 | 2 | 29661828 | ||
| Pubmed | Regulation of PDGFC signalling and extracellular matrix composition by FREM1 in mice. | 1.75e-04 | 6 | 120 | 2 | 24046351 | |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | 1.86e-04 | 454 | 120 | 8 | 33226137 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 1.91e-04 | 714 | 120 | 10 | 28302793 | |
| Pubmed | 2.45e-04 | 7 | 120 | 2 | 32960816 | ||
| Pubmed | Regional localization of the nu mutation on mouse chromosome 11. | 2.45e-04 | 7 | 120 | 2 | 8423056 | |
| Pubmed | 2.45e-04 | 7 | 120 | 2 | 11867212 | ||
| Pubmed | Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint. | 2.45e-04 | 7 | 120 | 2 | 20818375 | |
| Pubmed | 2.45e-04 | 7 | 120 | 2 | 23190742 | ||
| Pubmed | 2.45e-04 | 7 | 120 | 2 | 17259968 | ||
| Pubmed | O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma. | 2.61e-04 | 254 | 120 | 6 | 36604567 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 2.67e-04 | 361 | 120 | 7 | 30344098 | |
| Pubmed | 2.86e-04 | 37 | 120 | 3 | 10337614 | ||
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 3.20e-04 | 372 | 120 | 7 | 22939624 | |
| Pubmed | 3.26e-04 | 8 | 120 | 2 | 29946151 | ||
| GeneFamily | Adhesion G protein-coupled receptors, subfamily B | 4.42e-05 | 3 | 70 | 2 | 912 | |
| GeneFamily | WD repeat domain containing | 6.82e-05 | 262 | 70 | 7 | 362 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.05e-04 | 34 | 70 | 3 | 487 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.42e-03 | 19 | 70 | 2 | 50 | |
| GeneFamily | F-box and leucine rich repeat proteins | 2.96e-03 | 21 | 70 | 2 | 558 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP | 2.41e-06 | 200 | 112 | 8 | M6629 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-08 | 184 | 113 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-08 | 184 | 113 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-08 | 184 | 113 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.57e-07 | 184 | 113 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.99e-07 | 196 | 113 | 7 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.99e-07 | 196 | 113 | 7 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.74e-07 | 199 | 113 | 7 | bfc157be6e9f84739848eb19b718de5b17f3fa88 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l26|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.94e-06 | 156 | 113 | 6 | da5cfa8fa9595613f04ce9511f8b42bad34d995a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 160 | 113 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 160 | 113 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.82e-06 | 170 | 113 | 6 | 60bbd738c12e64e483485586c30057304884f5a6 | |
| ToppCell | ASK440-Immune-Mast_cell|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.27e-06 | 178 | 113 | 6 | dcefc4afca3a40d1bd44722e66bca6b45a6c6c55 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-06 | 189 | 113 | 6 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-06 | 189 | 113 | 6 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.95e-06 | 193 | 113 | 6 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-05 | 194 | 113 | 6 | c53478057674d70b79df8a3f476d15dea1925753 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.02e-05 | 194 | 113 | 6 | 2ab3f75b795a0ee4fe0f8eeba33093fcc77935f5 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.02e-05 | 194 | 113 | 6 | 8805c90e4284a81a6c8078f2d2417ae77b4e5c63 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-05 | 194 | 113 | 6 | 86d52467b05a0018517377c9c441245501f71d91 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 195 | 113 | 6 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 195 | 113 | 6 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intermediate_macrophages|Lung / Manually curated celltypes from each tissue | 1.12e-05 | 197 | 113 | 6 | bcb4dc17dae705bd84ea6a2842d6b107562baeb7 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-05 | 198 | 113 | 6 | 7d2fe57e0f9311ac1e6854402ebc154306eb1ba5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-05 | 200 | 113 | 6 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-05 | 200 | 113 | 6 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 3.68e-05 | 147 | 113 | 5 | 87c24843cb0e87ad42e725d08423131a5d2d25a3 | |
| ToppCell | 356C-Myeloid-Mast_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.80e-05 | 148 | 113 | 5 | 1668d8a9e680da335362744f36b05446c499347e | |
| ToppCell | 356C-Myeloid-Mast_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.80e-05 | 148 | 113 | 5 | 18511ba10765eda937c5a710626361f7e6b9b321 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.92e-05 | 149 | 113 | 5 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_C|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.18e-05 | 151 | 113 | 5 | 3f2abaa42876ce7a71d934ff16abe0cab0991a05 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.34e-05 | 159 | 113 | 5 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.54e-05 | 171 | 113 | 5 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.54e-05 | 171 | 113 | 5 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|(0)_Normal/No_Treatment / Stress and Cell class | 7.96e-05 | 173 | 113 | 5 | c2a0f674681836b5a868c13f67caa7d555ef6519 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-05 | 174 | 113 | 5 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-05 | 174 | 113 | 5 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.63e-05 | 176 | 113 | 5 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.87e-05 | 177 | 113 | 5 | 86c41d262142eeaa95ea7fa6668169eb1bb2953f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.10e-05 | 178 | 113 | 5 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.35e-05 | 179 | 113 | 5 | 898425fa81526a2e00fca7a25085229ff1f31069 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.35e-05 | 179 | 113 | 5 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.35e-05 | 179 | 113 | 5 | 2fca4117c58824562ec80c7713fe15689a28efb3 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.60e-05 | 180 | 113 | 5 | f3d8329b7e754c1ed89b0f39b8cd9e2ae22f6725 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.60e-05 | 180 | 113 | 5 | dcec59d66995f701d816eaeea3ed1439a2f71b73 | |
| ToppCell | Control-Myeloid-MoAM2|Control / Disease group,lineage and cell class (2021.01.30) | 9.60e-05 | 180 | 113 | 5 | 38892483a6a5388765aec87f0119c0b9bb5c7cbd | |
| ToppCell | facs-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.60e-05 | 180 | 113 | 5 | c0c3144011856d005aebd5cdc79f89fee32083a8 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 183 | 113 | 5 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 185 | 113 | 5 | 8433a337625ff8398520e223ef92bf9bb0beb14c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 185 | 113 | 5 | 049d793d043d5d434f143025de49dd210d18756c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 185 | 113 | 5 | 63200c42565eea596f9b00728e70e544b8d50a7f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 186 | 113 | 5 | 1094c7140131454b2583200e1c01e81ccab3db23 | |
| ToppCell | SMG-Goblet|World / shred by cell class for bronchial biopsy | 1.15e-04 | 187 | 113 | 5 | 5178118bdec91495253c88f58fd908cf831de7ef | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 1.21e-04 | 189 | 113 | 5 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | ASK440-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.21e-04 | 189 | 113 | 5 | 72a19b20cb0f7283afe5f85d62a21cff69fd78d0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-04 | 189 | 113 | 5 | 979b7fa947538aa7ca4a219263da2575869a2caa | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-04 | 190 | 113 | 5 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 190 | 113 | 5 | f61e21d53f2f7804ac6e40ab6c7f69838aa94d6a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-04 | 190 | 113 | 5 | be2b184a3559da41ba387ae0fdbeb9ae532868a5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-04 | 190 | 113 | 5 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.24e-04 | 190 | 113 | 5 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.27e-04 | 191 | 113 | 5 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-04 | 191 | 113 | 5 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.27e-04 | 191 | 113 | 5 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 191 | 113 | 5 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.30e-04 | 192 | 113 | 5 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.30e-04 | 192 | 113 | 5 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-04 | 192 | 113 | 5 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 192 | 113 | 5 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.30e-04 | 192 | 113 | 5 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-04 | 192 | 113 | 5 | 342842378c20267c5044bdd622515e8b9f895623 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-04 | 192 | 113 | 5 | bd3fa6c8fcb618db64d11f25cabaf08608957c35 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-04 | 192 | 113 | 5 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.30e-04 | 192 | 113 | 5 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-04 | 192 | 113 | 5 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-04 | 193 | 113 | 5 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.33e-04 | 193 | 113 | 5 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 193 | 113 | 5 | e5016959f24370579a8770787e96869f264cf7b3 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 193 | 113 | 5 | 8084fa0ce61f1f4a728423b6b81df04eaa5af5b6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-04 | 193 | 113 | 5 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 193 | 113 | 5 | 160691b671710be10220803d788c2c961c236af1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 194 | 113 | 5 | 6ac759828c41ffa974ee82842162caa959351dd1 | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.36e-04 | 194 | 113 | 5 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 194 | 113 | 5 | 5d0b0d8e96f0e0297a4dba70a05d87081a4eb323 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 194 | 113 | 5 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 194 | 113 | 5 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.36e-04 | 194 | 113 | 5 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 195 | 113 | 5 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 195 | 113 | 5 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | normal_Lung-B_lymphocytes-Follicular_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.40e-04 | 195 | 113 | 5 | 2a9a2b36a9a4ce72a3b855c0872214f38a7c64b0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-04 | 195 | 113 | 5 | 98ca9f3aa36211dde1e6f7f3817b9418c95e583e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 195 | 113 | 5 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 196 | 113 | 5 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.43e-04 | 196 | 113 | 5 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 196 | 113 | 5 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 196 | 113 | 5 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.43e-04 | 196 | 113 | 5 | eed9fe83ffc1f79493b70778962a671dd9f481e0 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 196 | 113 | 5 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-04 | 197 | 113 | 5 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 197 | 113 | 5 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-04 | 197 | 113 | 5 | 2744cc94883c5d0424677cf5093bbab622933e9b | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 6.49e-07 | 198 | 113 | 9 | 6073_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 5.73e-06 | 194 | 113 | 8 | 3606_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 5.73e-06 | 194 | 113 | 8 | 4309_DN | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 5.95e-06 | 195 | 113 | 8 | 983_UP | |
| Drug | (-)-depudecin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 6.18e-06 | 196 | 113 | 8 | 982_DN | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; PC3; HT_HG-U133A | 6.66e-06 | 198 | 113 | 8 | 4258_DN | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; HL60; HT_HG-U133A | 6.66e-06 | 198 | 113 | 8 | 2447_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; PC3; HT_HG-U133A | 6.66e-06 | 198 | 113 | 8 | 3706_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; PC3; HG-U133A | 4.18e-05 | 187 | 113 | 7 | 448_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A_EA | 4.94e-05 | 192 | 113 | 7 | 1047_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 5.28e-05 | 194 | 113 | 7 | 6201_DN | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; HL60; HT_HG-U133A | 5.28e-05 | 194 | 113 | 7 | 2434_DN | |
| Drug | Bromopride [4093-35-0]; Down 200; 11.6uM; PC3; HT_HG-U133A | 5.45e-05 | 195 | 113 | 7 | 3719_DN | |
| Drug | Betulinic acid [472-15-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 5.63e-05 | 196 | 113 | 7 | 4101_DN | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 5.63e-05 | 196 | 113 | 7 | 3208_DN | |
| Drug | Nadide [53-84-9]; Up 200; 6uM; MCF7; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 6091_UP | |
| Drug | (cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; MCF7; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 3889_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; PC3; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 4447_DN | |
| Drug | Flufenamic acid [530-78-9]; Down 200; 14.2uM; PC3; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 5059_DN | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; HL60; HT_HG-U133A | 6.20e-05 | 199 | 113 | 7 | 3079_DN | |
| Drug | Thiocolchicoside [602-41-5]; Down 200; 7uM; PC3; HT_HG-U133A | 6.20e-05 | 199 | 113 | 7 | 5095_DN | |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; HL60; HT_HG-U133A | 6.39e-05 | 200 | 113 | 7 | 2558_UP | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HG-U133A | 6.39e-05 | 200 | 113 | 7 | 418_UP | |
| Disease | dehydroepiandrosterone sulphate measurement | 1.15e-04 | 68 | 108 | 4 | EFO_0007001 | |
| Disease | acute promyelocytic leukemia (is_marker_for) | 1.97e-04 | 6 | 108 | 2 | DOID:0060318 (is_marker_for) | |
| Disease | cleft palate (implicated_via_orthology) | 3.66e-04 | 8 | 108 | 2 | DOID:674 (implicated_via_orthology) | |
| Disease | pulse pressure measurement, migraine without aura, susceptibility to, 4 | 4.70e-04 | 9 | 108 | 2 | EFO_0005763, MONDO_0011847 | |
| Disease | PR interval | 4.82e-04 | 495 | 108 | 8 | EFO_0004462 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 1.17e-03 | 14 | 108 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 36:5 measurement | 1.17e-03 | 14 | 108 | 2 | EFO_0010383 | |
| Disease | hepatoblastoma (is_marker_for) | 1.35e-03 | 15 | 108 | 2 | DOID:687 (is_marker_for) | |
| Disease | DiGeorge Syndrome | 1.54e-03 | 16 | 108 | 2 | C0012236 | |
| Disease | CONOTRUNCAL ANOMALY FACE SYNDROME | 1.54e-03 | 16 | 108 | 2 | C0795907 | |
| Disease | Intrahepatic cholestasis of pregnancy | 1.54e-03 | 16 | 108 | 2 | EFO_0009048 | |
| Disease | Shprintzen syndrome | 1.54e-03 | 16 | 108 | 2 | C0220704 | |
| Disease | spine bone size | 1.95e-03 | 18 | 108 | 2 | EFO_0004508 | |
| Disease | migraine disorder, systolic blood pressure | 1.95e-03 | 18 | 108 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | iron biomarker measurement, transferrin measurement | 2.42e-03 | 20 | 108 | 2 | EFO_0004461, EFO_0006341 | |
| Disease | prostate cancer (is_marker_for) | 2.63e-03 | 156 | 108 | 4 | DOID:10283 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_implicated_in) | 2.92e-03 | 22 | 108 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 2.92e-03 | 22 | 108 | 2 | EFO_0021115 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CIGQWDRKDIKKGEK | 451 | Q99798 | |
| KSKKQRAGSERCPWA | 1111 | O60241 | |
| LKRGKEACALDTVGW | 66 | P22362 | |
| PNKGSKRCLRKVDWL | 86 | A6NKX1 | |
| ELLRAKLIECGWKDQ | 31 | Q9NPA8 | |
| GYCWKKRKDGKTTRE | 121 | Q9Y6Y1 | |
| LGRGAAVDCLKKADW | 91 | Q6P6B7 | |
| KDRTWNGTKPVCKAL | 2996 | Q7Z408 | |
| KKLKERAGASLWSSC | 1126 | O14514 | |
| SKFWIGLQREKGKCL | 91 | Q9NPY3 | |
| GGSKRNALLKWCQKK | 961 | Q5M775 | |
| GSKRNALLKWCQKKT | 1011 | Q69YQ0 | |
| KIRCANETKTWEEGK | 701 | Q12797 | |
| ILKQGGAVKFRDKEW | 91 | Q9NW81 | |
| TVRGWCKNKRVGKQL | 661 | Q8WYQ5 | |
| KAGDGSKKIKGCWDS | 136 | P47756 | |
| ENRLLKLEEGKCWFG | 216 | Q6DHV5 | |
| TCGKGWRKRAVACKS | 1001 | Q8TE57 | |
| KWGRSQAARGKEKEK | 301 | Q9NW64 | |
| GVAKCWVARKALDKA | 291 | Q13702 | |
| CLGCIWSRRDKKENK | 256 | Q9NZL6 | |
| LWCKVEGEKECRTKL | 591 | Q8TE59 | |
| TGCQIDWKKGKNVTL | 256 | P55209 | |
| AKCIKGDSSIQKRWK | 276 | P17706 | |
| EKRKLENEGQKCELW | 246 | Q96MZ0 | |
| DKRKGLGLWGAEELC | 231 | Q6Y2X3 | |
| KDVKGALCRLLEWVK | 301 | Q8NGR6 | |
| KEALKRWLGTCVNLK | 296 | Q8NG77 | |
| CRKNNGKTEIWLELK | 96 | Q04759 | |
| KKGWCKEASALVCIR | 51 | O95944 | |
| LRKGSVLVAGKCWAK | 381 | P46199 | |
| SCGKKGVLDWLIQKG | 61 | Q9P2D0 | |
| KEWKRNDKIELLVGC | 216 | Q4FZB7 | |
| LFLCGRWLSLKKEDG | 1351 | Q8IVV2 | |
| DWLSQRKGKKTLVCE | 1651 | Q8IVV2 | |
| KLKLACGRGWLNQDD | 401 | Q5VW00 | |
| ECGGINLKLEELEWK | 181 | Q8N4E4 | |
| GKIWRSKCCKGISGK | 21 | O43731 | |
| WLEIKEGKLGCKDCS | 151 | Q9HCI6 | |
| PNKGSKRCLRKVDWL | 86 | Q8IWN6 | |
| KLGKSCVLVQRQGKW | 2146 | Q5H8C1 | |
| RGKELAWEKLLFGVC | 2636 | Q6ZR08 | |
| ISGSCKKRWLKQALE | 811 | Q8IZD2 | |
| IRCGELTWQKGLLKK | 321 | Q6ZV70 | |
| WDKKTEKLCGLIDCV | 2376 | Q5S007 | |
| STGKSVGKWEVKDCR | 601 | O60449 | |
| RDVQDECKKKGLPWT | 106 | Q6P587 | |
| KSWSLGVCKEPADRK | 156 | Q6ZWI9 | |
| CGKSLPEWLSDRKKR | 16 | Q9BSC4 | |
| KNSEVKGALKRWLGT | 291 | Q8NG76 | |
| KGALKRWLGTCVNIK | 296 | Q8NG76 | |
| IKKWDICAGNAILKA | 296 | Q9NX62 | |
| AAVCKEKIGWRKDAL | 256 | P18084 | |
| KTLKNLLGKSCEWFE | 416 | A2RRP1 | |
| LNKWQLDKKLGCGCL | 601 | Q9HC58 | |
| VDRLWQKKCQSKSPG | 401 | Q68CR7 | |
| VSELKKRAGWQGLCD | 491 | P51956 | |
| GEDWGDKKVICNKFI | 96 | Q9UG01 | |
| WKGKDLFDLVCRTLG | 41 | P35240 | |
| GDILKSKKRQGWRTC | 321 | Q86YG4 | |
| IKCGWLRKQGGFVKT | 21 | Q8N264 | |
| EQGTLDLKDWKRIGK | 51 | Q9YNA8 | |
| EQGTLDLKDWKRIGK | 51 | P62683 | |
| EQGTLDLKDWKRIGK | 51 | P63145 | |
| EQGTLDLKDWKRIGK | 51 | Q7LDI9 | |
| EQGTLDLKDWKRIGK | 51 | P63130 | |
| EQGTLDLKDWKRIGK | 51 | P62685 | |
| EQGTLDLKDWKRIGK | 51 | P63126 | |
| EQGTLDLKDWKRIGK | 51 | P62684 | |
| QDKCLIDLGKWCSEK | 636 | Q92896 | |
| GCSKKTNEWGKTIIE | 1316 | P08123 | |
| IASLEKSVLGCWKGL | 1791 | Q14674 | |
| GKCWENGIILCRKIA | 1266 | Q8N1I0 | |
| IQGCWRQLLKECKEK | 1321 | Q5THR3 | |
| KNCWEKLGEVALLQG | 671 | P53621 | |
| CRKLDELGSKGLWAD | 41 | O75508 | |
| EKSKGDINLVKQGCW | 71 | Q13873 | |
| CGKGGDLLKWKKGRI | 206 | O43148 | |
| RDWKESVASKGQKCL | 151 | Q86Y33 | |
| WLRGLCKKGDQCEFL | 71 | O95639 | |
| LKIWKSRSCAGISGK | 21 | P24390 | |
| VKLSRLKCNREGKEW | 716 | P54198 | |
| LCGFLWTRKGKLKIE | 11 | Q9BPW9 | |
| FKKSWGCGLESKKNE | 281 | Q86YT5 | |
| LKEEKCQWSKERAGL | 401 | Q9P1Z2 | |
| DGKREVVCLCWLKKA | 541 | Q3KNS1 | |
| WKEAKGGEICEQLRA | 221 | Q5ST30 | |
| CATLWKQKVLGRGGK | 926 | A8K8P3 | |
| CNGKWNKVIIKKEGS | 1796 | O75445 | |
| KISAIVWEGNDCKKA | 461 | Q8N3S3 | |
| CQVLDGGKWRLSGKV | 1886 | A0AVI2 | |
| TKACKRWRDTDGKKQ | 131 | Q92901 | |
| KWKDDVIKLCGRELV | 26 | P04808 | |
| LLLQATALDGKKKCW | 41 | Q9Y2K3 | |
| KHLKGRLGKQCRERW | 111 | P10244 | |
| RKGCLWALNPAKIDK | 341 | O15353 | |
| GLGWEGQEAEKILCK | 291 | Q9NXK8 | |
| GEKWENEFCKLIRKL | 191 | Q6ZW05 | |
| ASSVLRCGKKKVWLD | 11 | P84098 | |
| QGCLALAELLGWKKE | 326 | Q8IXJ6 | |
| IEDCKGCKIDWRRGK | 396 | Q99457 | |
| DKAQLLRKGVSGDWK | 241 | Q06520 | |
| RKKVDGKLLCWLCTL | 116 | Q8TAV0 | |
| EQGTLDLKDWKRIGK | 51 | P63128 | |
| QNKGWGIRCLDDIAK | 811 | Q15047 | |
| DKIKIKIADLGNACW | 401 | Q9UPE1 | |
| QELGKDKWLCPLSGK | 706 | Q9BXP5 | |
| ARKKGLKGTWEELCN | 636 | O95573 | |
| ENWGGFLRFKKGKRC | 66 | Q7LFX5 | |
| IGNKKNQEIWGIKCR | 401 | Q13309 | |
| IKEGGKSNEWRLKCI | 951 | Q86UP3 | |
| LRQEGLVKGKDDTWK | 11 | O14709 | |
| GKIKVWKIQSGQCLR | 286 | Q2TAY7 | |
| ANDKLKWCLRVNPKG | 61 | O43791 | |
| AKSICRLAWQPKSGK | 186 | O75717 | |
| DNKKLGEWVGLCKID | 81 | P25398 | |
| SNGKDLKCEWELLER | 736 | O00534 | |
| KCRKAGVGQSWKENS | 276 | P13726 | |
| RKCQKILGKNAALWE | 416 | P49754 | |
| TSPEGWKLLKKDLCN | 1351 | P78527 | |
| NGCGKAFIWKSRLKI | 596 | P51814 | |
| GCKRQGKLSESIKWR | 561 | O95789 | |
| INWQVLKDRKGRCGK | 136 | Q9P2T0 | |
| GAVWKALFGKEADKL | 91 | Q8IUR0 | |
| WEKDGRCLQNSKRLG | 946 | P82987 |